On December 23, 2021, CVR Medical Corp. closed the transaction. The company amended the terms of the transaction and issued 3,850,000 units at a price CAD 0.030 per unit for gross proceeds of CAD 115,500 in the transaction. The transaction included participation from 2 placees, chief executive officer, Darren Day, for 2,783,333 units, board of director, Joseph A. Lynch for 1,066,667 units and other investors.

On January 7, 2022, the TSX Venture Exchange has accepted for filing documentation with respect to the transaction.